MyFinsight
Home
About
Contact
Back
Income Statement
AbCellera Biologics Inc. (ABCL)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$30,386K
(18.29%↑ Y/Y)
Foreign currency
translation adjustment
$4,341K
(1789.11%↑ Y/Y)
Net loss
-$34,727K
(5.97%↑ Y/Y)
Income tax recovery
-$1,617K
(85.64%↑ Y/Y)
Grants and incentives
$3,692K
(11.54%↑ Y/Y)
Interest income
$7,592K
(-22.54%↓ Y/Y)
Other
$1,957K
(-93.91%↓ Y/Y)
Net loss before
income tax
-$36,344K
(24.58%↑ Y/Y)
Total other income
$13,241K
(-70.75%↓ Y/Y)
Research Fees
$6,639K
License
$10,445K
Loss from operations
-$49,585K
(46.94%↑ Y/Y)
Total revenue
$17,084K
(133.29%↑ Y/Y)
Total operating
expenses
$66,669K
(-33.85%↓ Y/Y)
Depreciation, amortization,
and impairment
$5,470K
General and
administrative
$18,977K
(-6.02%↓ Y/Y)
Research and development
$39,213K
(-4.19%↓ Y/Y)
Sales and marketing
$3,009K
(-4.05%↓ Y/Y)
Back